AvePoint Sees Q2 Sales $120.300M-$122.300M vs $124.198M Est

Benzinga Newsdesk www.benzinga.com Positive 81.5%

Neg 0% Neu 0% Pos 81.5%

AvePoint (NASDAQ:AVPT) sees Q2 sales of $120.300 million-$122.300 million vs $124.198 million analyst estimate.

Comments

No comments yet. Be the first!